What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Interview with IgA Nephropathy Patient Alex

Leicester IgA Nephropathy

L. Iga Nephropathy

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Catheter-Related Bloodstream Infection (CRBSI): An Update of Prevent…

National Kidney Foundation

S. Kant, M. Fisher, D. Edwards

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

APOL1 Controversies Conference Plenary: APOL1 Pathophysiology

KDIGO

D. Friedman

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

Multivitamins and Health: What Do We Know?

Joanne Manson

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Regenerating Kidney Tissue to Combat Nephropathic Cystinosis

Benjamin Freedman

Peritoneal Dialysis in ADPKD

Columbia University

S. Shirazian

Treatment of Fabry Disease

Ankit Mehta

Interview with IgA Nephropathy Patient Alistair

Leicester IgA Nephropathy

L. Iga Nephropathy

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

Robert Busch

A New Paradigm: Rethinking Hypherphosphatemia Management

Icahn School of Medicine at Mount Sinai

D. Spiegel